Global Artificial Saliva Market Outlook 2022

Saliva plays an important role in chewing, swallowing, digesting, and speaking. It also helps control bacteria in your mouth, which helps prevent infection and tooth decay. Artificial saliva can relieve the symptoms of dry mouth and help you avoid health complications.
The World Health Organization data shows that oral diseases are the fourth-most expensive disease to treat in both emerging and developed economies. Oral health maintenance expenditure is a major healthcare issue directly impacting the artificial saliva market. As the artificial saliva market is consumer-based, increase in disposable income and per-capita spending are likely to drive the artificial saliva market over the course of the forecast period. A critical issue to be resolved before that is the demand-supply imbalance in the artificial saliva market that affects everybody from manufacturers to end consumers. Any supply chain deviation leads to a rise in price, reducing the ability of key players to offer products at competitive prices and boost the overall profile of the artificial saliva market.

The global Artificial Saliva market was valued at US$ 262.2 million in 2020 and is expected to reach US$ 465 million by the end of 2027, growing at a CAGR of 8.1% during 2021-2027.
This report focuses on Artificial Saliva volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Artificial Saliva market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Artificial Saliva Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Oral Spray
Oral Solution
Oral Liquid
Gel
Powder

Segment by Application
Adult
Paediatric

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
GlaxoSmithKline
Cipla Limited
Fresenius Kabi
Parnell Pharmaceuticals
Entod International
Forward Science
Biocosmetics Laboratories
Icpa Health Products LTD.
Perrigo
Laboratorios Kin